Genetically modified human placenta-derived mesenchymal stem cells with FGF-2 and PDGF-BB enhance neovascularization in a model of hindlimb ischemia

Ischemic diseases represent a challenging worldwide health burden. The current study investigated the therapeutic potential of genetically modified human placenta-derived mesenchymal stem cells (hPDMSCs) with basic fibroblast growth factor (FGF2) and platelet-derived growth factor-BB (PDGF-BB) genes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Med Rep
Main Authors: YIN, TAO, HE, SISI, SU, CHAO, CHEN, XIANCHENG, ZHANG, DONGMEI, WAN, YANG, YE, TINGHONG, SHEN, GUOBO, WANG, YONGSHENG, SHI, HUASHAN, YANG, LI, WEI, YUQUAN
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4581748/
https://ncbi.nlm.nih.gov/pubmed/26239842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.4089
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados